Home › Funds › Propel Bio Management, LLC › SLN

Propel Bio Management, LLC position in SLN

SILENCE THERAPEUTICS PLC · Health Care

Propel Bio Management, LLC reported holding 191,733 shares of SLN (SILENCE THERAPEUTICS PLC) in its Q2 2026 13F filing — a position valued at US$2.1M, representing 1.10% of its reported portfolio and ranking #25 among its reported holdings. Propel Bio Management, LLC first reported this position in Q2 2026.

Latest position (Q2 2026)191.73K sh
Reported value held$2.11M
Portfolio Weight1.10%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Propel Bio Management, LLC's SLN position evolved

Propel Bio Management, LLC first disclosed a stake in SLN in Q2 2026 at 191,733 shares (US$2.1M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 191.73K $2.11M New

About SLN and 13F data

SLN (SILENCE THERAPEUTICS PLC) is a Health Care company. 35 other funds we track also report a position in SLN — the largest reported positions include Siren, L.L.C. (US$36.4M), TCG Crossover Management, LLC (US$33.3M), Redmile Group, LLC (US$23.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SLN

All SLN fund holders →

FAQ

How long has Propel Bio Management, LLC held SLN?

Propel Bio Management, LLC has disclosed SLN holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Propel Bio Management, LLC's current position in SLN?

As of Q2 2026, Propel Bio Management, LLC holds 191.73K shares of SLN (SILENCE THERAPEUTICS PLC), valued at $2.11M, representing 1.10% of its reported portfolio and ranking #25.

Has Propel Bio Management, LLC been buying or selling SLN?

In the latest 13F filing (Q2 2026), Propel Bio Management, LLC newly opened its position in SLN.

Which other funds hold SLN?

Other major institutional holders of SLN include Siren, L.L.C., TCG Crossover Management, LLC, Redmile Group, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.